Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fedele Dono

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Epilepsia Open|August 10, 2023
Autoimmune encephalitis during pregnancy: A diagnostic and therapeutic challenge-A systematic review with individual patients' analysis and clinical recommendationsFedele Dono, Stefano Consoli, Maria Tappatà, et al.
Epilepsia Open|September 9, 2022
Effectiveness of perampanel as the only add-on: Retrospective, multicenter, observational real-life study on epilepsy patientsSara Gasparini, Edoardo Ferlazzo, Sabrina Neri, et al.
Pediatric Neurology|October 11, 2023
A PAK1 Mutational Hotspot Within the Regulatory CRIPaK Domain is Associated With Severe Neurodevelopmental Disorders in ChildrenGiovanna Scorrano, Gianluca D'Onofrio, Andrea Accogli, et al.
Journal of the Neurological Sciences|November 17, 2023
Perampanel as only add-on epilepsy treatment in elderly: A subgroup analysis of real-world data from retrospective, multicenter, observational studyAngelo Pascarella, Sara Gasparini, Lucia Manzo, et al.
Journal of Neurology|June 7, 2025
Effectiveness of perampanel as only concomitant antiseizure medication for highly active epilepsy: insight from a real-world, multicenter retrospective studyAngelo Pascarella, Marilisa Pasquale, Domenico Abelardo, et al.
Journal of the Neurological Sciences|June 26, 2024
Perampanel in post-stroke epilepsy: Clinical practice data from the PERampanel as Only Concomitant antiseizure medication (PEROC) studyAngelo Pascarella, Lucia Manzo, Sara Gasparini, et al.
Seizure|July 23, 2021
Predictive factors of Status Epilepticus and its recurrence in patients with adult-onset seizures: A multicenter, long follow-up cohort studySara Gasparini, Edoardo Ferlazzo, Gianluigi Gigli, et al.
Neurology and Therapy|November 20, 2025
Lacosamide is Associated with a Higher Treatment Persistence at 12 Months than Brivaracetam and Perampanel Despite Similar EfficacyRoberta Roberti, Cristina Politi, Francesca Anzellotti, et al.
Epilepsia|December 5, 2023
A real-world comparison among third-generation antiseizure medications: Results from the COMPARE studyRoberta Roberti, Gianfranco Di Gennaro, Francesca Anzellotti, et al.
JAMA Neurology|February 9, 2026
Comparative Effectiveness of Brivaracetam, Cenobamate, Lacosamide, and Perampanel in Focal EpilepsyEmanuele Cerulli Irelli, Roberta Roberti, Maria Sole Borioni, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Epilepsia Open|August 10, 2023
Autoimmune encephalitis during pregnancy: A diagnostic and therapeutic challenge-A systematic review with individual patients' analysis and clinical recommendationsFedele Dono, Stefano Consoli, Maria Tappatà, et al.
Epilepsia Open|September 9, 2022
Effectiveness of perampanel as the only add-on: Retrospective, multicenter, observational real-life study on epilepsy patientsSara Gasparini, Edoardo Ferlazzo, Sabrina Neri, et al.
Pediatric Neurology|October 11, 2023
A PAK1 Mutational Hotspot Within the Regulatory CRIPaK Domain is Associated With Severe Neurodevelopmental Disorders in ChildrenGiovanna Scorrano, Gianluca D'Onofrio, Andrea Accogli, et al.
Journal of the Neurological Sciences|November 17, 2023
Perampanel as only add-on epilepsy treatment in elderly: A subgroup analysis of real-world data from retrospective, multicenter, observational studyAngelo Pascarella, Sara Gasparini, Lucia Manzo, et al.
Journal of Neurology|June 7, 2025
Effectiveness of perampanel as only concomitant antiseizure medication for highly active epilepsy: insight from a real-world, multicenter retrospective studyAngelo Pascarella, Marilisa Pasquale, Domenico Abelardo, et al.
Journal of the Neurological Sciences|June 26, 2024
Perampanel in post-stroke epilepsy: Clinical practice data from the PERampanel as Only Concomitant antiseizure medication (PEROC) studyAngelo Pascarella, Lucia Manzo, Sara Gasparini, et al.
Seizure|July 23, 2021
Predictive factors of Status Epilepticus and its recurrence in patients with adult-onset seizures: A multicenter, long follow-up cohort studySara Gasparini, Edoardo Ferlazzo, Gianluigi Gigli, et al.
Neurology and Therapy|November 20, 2025
Lacosamide is Associated with a Higher Treatment Persistence at 12 Months than Brivaracetam and Perampanel Despite Similar EfficacyRoberta Roberti, Cristina Politi, Francesca Anzellotti, et al.
Epilepsia|December 5, 2023
A real-world comparison among third-generation antiseizure medications: Results from the COMPARE studyRoberta Roberti, Gianfranco Di Gennaro, Francesca Anzellotti, et al.
JAMA Neurology|February 9, 2026
Comparative Effectiveness of Brivaracetam, Cenobamate, Lacosamide, and Perampanel in Focal EpilepsyEmanuele Cerulli Irelli, Roberta Roberti, Maria Sole Borioni, et al.
Pageof 8